Ownership

Frank Ruffo

Insider Reports History

Entity: Individual
Location: C/O Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern, PA
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Ruffo:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Aclaris Therapeutics, Inc.	Chief Financial Officer	Common Stock	202K	$212K	$1.05	Mar 10, 2022	Direct

Showing 1 to 1 of 1 entries

Insider Reports Filed by Frank Ruffo

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ACRS	Aclaris Therapeutics, Inc.	Mar 10, 2022	1	-$199K	4	Mar 14, 2022	Chief Financial Officer
ACRS	Aclaris Therapeutics, Inc.	Mar 1, 2022	8	$0	4	Mar 3, 2022	Chief Financial Officer
ACRS	Aclaris Therapeutics, Inc.	Feb 9, 2022	1	-$17.6K	4	Feb 11, 2022	Chief Financial Officer
ACRS	Aclaris Therapeutics, Inc.	Feb 1, 2022	2	$0	4	Feb 3, 2022	Chief Financial Officer
ACRS	Aclaris Therapeutics, Inc.	Jun 1, 2021	4	-$325K	4	Jun 2, 2021	Chief Financial Officer